ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2166

Treatment of Venous Thrombotic Events in Behçet Disease: A Systematic Literature Review

Iustina Janta1, Roberto González2, Tania Gudu3 and Indalecio Monteagudo1, 1Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, 2Rheumatology, Hospital general Universitario Gregorio Marañón, Madrid, Spain, 3University of Medicine Carol Davila Bucuresti, Romania, Bucuresti, Romania

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, thrombosis and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Epidemiology and Public Health Poster III: SLE, SSc, APS, PsA, and Other Rheumatic Diseases

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Venous thrombosis (VT) is a serious and potentially life-threatening manifestation of Behçet disease (BD). However, there is little evidence of the management of the VT in BD. To review the treatment used in venous thrombotic events in BD.

Methods: A systematic review was performed according to the PICO approach. Several synonyms for the main components (i.e. Behçet, venous thrombosis, treatment) were used. The literature search was performed in Medline and Embase from databases inception to 1st November 2017. Only articles in English and Latin languages were retained. We excluded abstracts, reviews or letters. From the selected studies, data about the VT, treatment and treatment response were retired using a predefined data collection form.

Results: The literature search resulted in 1552 articles (figure 1). The main reason for article exclusion after full-text review was the lack of description of VT and its treatment. Finally, 26 articles were included in the analysis with a total of 1899 patients. Mean age (standard deviation, SD) was 32.8 (5.6) years and most of them were men (77.7%). The mean (SD) duration time between disease onset and VT onset was evaluated in only 16 articles and was 4.67 (2.9) years.

Superficial VT was evaluated in 34.6% articles, involving a number of 29 patients, deep VT in 76.9% articles and 291 patients, cerebral VT in 40.7% articles and 140 patients, inferior or superior cava vein VT in 73.1% articles and 270 patients and Budd-Chiari syndrome in 53.8% articles and 73 patients.

Details of the reported treatments are depicted in table 1. Due to the lack of detailed treatment description, no relationship between the type of treatment and the type of VT could be established. Treatment response was evaluated in 23 (88.5%) articles. A good treatment response, i.e., the thromb resolution was reported in 11 articles, corresponding to 161 patients. Death due to VT was reported in 10 articles (38.5%) and 24 patients. Complications and lack of treatment response were also reported: recurrences, extension or progression of the thromb (11 articles, 450 patients), aneurisms (6 articles, 28 patients), new thrombs (3 articles, 20 patients), post thrombotic complications (3 articles, 38 patients). However, data regarding treatment response were inconstantly reported and the outcomes used for assessing it were very heterogeneous. Therefore, correlations and predictive factors of complications or mortality could not be identified.  

Conclusion: There is a high variability in reporting treatment of VT related to BD with respect to type, indication and evaluation of response.


Disclosure: I. Janta, None; R. González, None; T. Gudu, None; I. Monteagudo, None.

To cite this abstract in AMA style:

Janta I, González R, Gudu T, Monteagudo I. Treatment of Venous Thrombotic Events in Behçet Disease: A Systematic Literature Review [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/treatment-of-venous-thrombotic-events-in-behcet-disease-a-systematic-literature-review/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/treatment-of-venous-thrombotic-events-in-behcet-disease-a-systematic-literature-review/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology